Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-017028

Chairman and CEO acquired 1,174 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KAZIMI A J Chairman and CEO 2023-12-01 Other acquisition 10b5-1 +72 $1.69 $122 5,720,165 D
KAZIMI A J Chairman and CEO 2023-12-04 Other acquisition 10b5-1 +64 $1.72 $110 5,720,229 D
KAZIMI A J Chairman and CEO 2023-12-05 Other acquisition 10b5-1 +72 $1.69 $122 5,720,301 D
KAZIMI A J Chairman and CEO 2023-12-06 Other acquisition 10b5-1 +72 $1.70 $122 5,720,373 D
KAZIMI A J Chairman and CEO 2023-12-07 Other acquisition 10b5-1 +34 $1.65 $56 5,720,407 D
KAZIMI A J Chairman and CEO 2023-12-08 Other acquisition 10b5-1 +72 $1.83 $132 5,720,479 D
KAZIMI A J Chairman and CEO 2023-12-11 Other acquisition 10b5-1 +82 $1.85 $152 5,720,561 D
KAZIMI A J Chairman and CEO 2023-12-12 Other acquisition 10b5-1 +87 $1.77 $154 5,720,648 D
KAZIMI A J Chairman and CEO 2023-12-13 Other acquisition 10b5-1 +82 $1.80 $148 5,720,730 D
KAZIMI A J Chairman and CEO 2023-12-14 Other acquisition 10b5-1 +82 $1.86 $153 5,720,812 D
KAZIMI A J Chairman and CEO 2023-12-15 Other acquisition 10b5-1 +82 $1.89 $155 5,720,894 D
KAZIMI A J Chairman and CEO 2023-12-18 Other acquisition 10b5-1 +81 $1.80 $146 5,720,975 D
KAZIMI A J Chairman and CEO 2023-12-19 Other acquisition 10b5-1 +81 $1.73 $140 5,721,056 D
KAZIMI A J Chairman and CEO 2023-12-20 Other acquisition 10b5-1 +124 $1.76 $218 5,721,180 D
KAZIMI A J Chairman and CEO 2023-12-21 Other acquisition 10b5-1 +87 $1.70 $148 5,721,267 D
Loading xslF345X05/marketforms-63937.xml…